Hasil Pencarian  ::  Simpan CSV :: Kembali

"ABSTRAKNon-alcoholic fatty liver disease (NAFLD) adalah penyakit hati kronik yang ditandai dengan akumulasi lemak berlebihan di hati. Elastografi Transien (ET) dan metode Controlled Attenuation Parameter (CAP) merupakan metode pemeriksaan non-invasif untuk menilai derajat fibrosis dan steatosis, namun tidak tersedia di seluruh rumah sakit di Indonesia. Rasio Neutrofil Limfosit (RNL) merupakan penanda peradangan sederhana yang berpotensi memprediksi luaran penyakit. Tujuan : Mengetahui nilai diagnostik RNL sebagai indikator derajat keparahan steatosis dan fibrosis NAFLD. Metode : Penelitian ini adalah studi potong lintang menggunakan data sekunder dari data rekam medis tahun 2016-2018. Analisis statistik deskriptif dan analitik berupa uji korelasi, Receiver Operating Curve (ROC) dan Area Under The Curve (AUC) dipakai untuk mengetahui luaran studi. Hasil : Dari 106 subjek penelitian, kebanyakan pasien adalah perempuan (62,3%) berusia rata-rata 57,29 tahun dan menderita sindrom metabolik (77,4%). Sebagian besar pasien memiliki derajat steatosis sedang-berat (66%) dengan rerata ET 6,14 (2,8-18,2). Terdapat korelasi antara nilai CAP (r=0,648; p<0,001) dan ET (r=0,621; p<0,001) dengan RNL. Penggunaan RNL untuk menilai derajat steatosis sedang-berat memiliki titik potong 1,775 dengan sensitivitas, spesifisitas, NDP dan NDN sebesar 81,5%, 80,6%, 89,1%, dan 69,1%; titik potong 2,150 untuk menilai fibrosis signifikan dengan sensitivitas, spesifisitas, NDP dan NDN berurutan sebesar 92,3 %; 87,5%; 70,6%; dan 97,2%. Simpulan : RNL memiliki korelasi positif dan signifikan terhadap derajat steatosis (CAP) dan fibrosis (ET) dengan sensitivitas dan spesifisitas yang cukup tinggi.

---

ABSTRACT

Non-alcoholic fatty liver disease (NAFLD) is a chronic inflammatory disease with excessive fat accumulation in the liver. Transient Elastography (TE) with Controlled Attenuation Parameter (CAP) is a device and method to examine the degree of fibrosis and steatosis. However, this device is not widely available across Indonesia. Neutrophil and Lymphocyte Ratio (NLR) is a simple marker for inflammation which has a potency to predict disease outcome. This study aims to know the diagnostic value of NLR as the indicator of steatosis and fibrosis severity. Methods: This was a cross-sectional study with consecutive sample collection. We used secondary data from medical record, starting from 2016-2018. A descriptive and analytic statistic, including correlation test, multivariate linear regression, t test, Receiver Operating Curve (ROC) and Area Under the Curve (AUC) were done to know the outcome of the study. Statistical analyses were performed using Statistical Package for Social Sciences (SPSS) Version 20.0 (SPSS Inc, Chicago, Illinois). A P value <0.05 was considered as statistically significant. Results: Out of 106 subjects, 62.3% patients were women with the mean of age 57.29 years old and 77.4% had metabolic syndrome. Most patients had moderate to severe steatosis degree (66%) with the mean of ET mean 6.14 (2.8-18.2). There was a positive correlation between CAP and TE compared with NLR with r=0.647 (p<0.001) and r=0.621 (p<0.001) respectively. The use of RNL to assess moderate-severe steatosis has a cutoff point of 1.775 with sensitivity,  specificity, PPV and NPV respectively at 81,5%, 80,6%, 89,1%, and 69,1%; cutoff point 2,150 to assess significant fibrosis with sensitivity, specificity, PPV and NPV of 92.3 %, 87.5%, 70.6%, and 97.2% respectively. Conclusion: NLR has a positive and significant correlation with the degree of steatosis and fibrosis with high sensitivity and specificity in comparison with TE/CAP."

"Latar Belakang : Non-alcoholic fatty liver disease (NAFLD) adalah penyakit hati kronik yang ditandai dengan akumulasi lemak berlebihan di hati. Elastografi Transien (ET) dan metode Controlled Attenuation Parameter (CAP) merupakan metode pemeriksaan non-invasif untuk menilai derajat fibrosis dan steatosis, namun tidak tersedia di seluruh rumah sakit di Indonesia. Rasio Neutrofil Limfosit (RNL) merupakan penanda peradangan sederhana yang berpotensi memprediksi luaran penyakit. Tujuan : Mengetahui nilai diagnostik RNL sebagai indikator derajat keparahan steatosis dan fibrosis NAFLD. Metode : Penelitian ini adalah studi potong lintang menggunakan data sekunder dari data rekam medis tahun 2016-2018. Analisis statistik deskriptif dan analitik berupa uji korelasi, Receiver Operating Curve (ROC) dan Area Under The Curve (AUC) dipakai untuk mengetahui luaran studi. Hasil : Dari 106 subjek penelitian, kebanyakan pasien adalah perempuan (62,3%) berusia rata-rata 57,29 tahun dan menderita sindrom metabolik (77,4%). Sebagian besar pasien memiliki derajat steatosis sedang-berat (66%) dengan rerata ET 6,14 (2,8-18,2). Terdapat korelasi antara nilai CAP (r=0,648; p<0,001) dan ET (r=0,621; p<0,001) dengan RNL. Penggunaan RNL untuk menilai derajat steatosis sedang-berat memiliki titik potong 1,775 dengan sensitivitas, spesifisitas, NDP dan NDN sebesar 81,5%, 80,6%, 89,1%, dan 69,1%; titik potong 2,150 untuk menilai fibrosis signifikan dengan sensitivitas, spesifisitas, NDP dan NDN berurutan sebesar 92.3 %, 87.5%, 70.6%, dan 97.2%. Simpulan : RNL memiliki korelasi positif terhadap derajat steatosis dan fibrosis dengan sensitivitas dan spesifisitas yang tinggi.

---

Introduction : Non-alcoholic fatty liver disease (NAFLD) is a chronic inflammatory disease with excessive fat accumulation in the liver. Transient Elastography (TE) with Controlled Attenuation Parameter (CAP) is a device and method to examine the degree of fibrosis and steatosis. However, this device is not widely available across Indonesia. Neutrophil and Lymphocyte Ratio (NLR) is a simple marker for inflammation which has a potency to predict disease outcome.

Objective : To know the diagnostic value of RNL as the indicator of steatosis and fibrosis severity.

Methods : This was a cross-sectional study using secondary data from the medical record, starting from 2016-2018 with the respective inclusion and exclusion criteria. A descriptive and analytic statistic, including correlation test, Receiver Operating Curve (ROC) and Area Under The Curve (AUC) were done to know the outcome of the study.

Result: Out of 106 subjects, 62.3% patients were women with aged mean 57.29 years old and 77.4% had metabolic syndrome. Most patients had average-severe steatosis degree (66%) with the mean of ET mean 6.14 (2.8-18.2). There was a positive correlation between CAP and TE compared with NLR with r = 0.647 (p<0.001) and r = 0.621 (p<0.001) respectively. The use of NLR to assess moderate-severe steatosis has a cutoff point of 1.775 with sensitivity, specificity, PPV and NPV of 81,5%, 80,6%, 89,1%, and 69,1%; cutoff point 2,150 to assess significant fibrosis with sensitivity, specificity, PPV and NPV of 92.3 %, 87.5%, 70.6%, 97.2% respectively.

Conclusion : NLR has a positive correlation with the degree of steatosis and fibrosis with high sensitivity and specificity."

"Latar belakang. Hiperurisemia merupakan salah satu parameter metabolik yang diperkirakan mempunyai peranan dalam perjalanan non-alcoholic liver disease NAFLD . Studi mengenai peranan asam urat dalam progresivitas penyakit hati masih terbatas.Tujuan. Mengetahui korelasi antara kadar asam urat dengan nilai Elastografi Transien ET dan Controlled Attenuation Parameter CAP pasien NAFLD.Metode. Penelitian ini merupakan studi potong lintang dengan menggunakan data sekunder yang melibatkan 113 pasien NAFLD dewasa. Dilakukan uji korelasi antara kadar asam urat dengan nilai ET dan nilai CAP. Lalu dilakukan analisis tambahan dengan membagi pasien menjadi 2 kelompok berdasarkan nilai ET dan CAP. Nilai titik potong ET untuk fibrosis signifikan sebesar ge; 7 kPa dan nilai CAP ge; 285 dB/m digunakan untuk membedakan steatosis ringan dan steatosis sedangberat. Faktor metabolik yang mempengaruhi derajat steatosis dan fibrosis dianalisis dengan menggunakan uji chi-square dan dilakukan analisis regresi logistik.Hasil. Terdapat 45 pasien dengan steatosis sedang-berat dan 34 pasien yang mengalami fibrosis signifikan. Tidak terdapat korelasi antara kadar asam urat dengan nilai CAP koefisien korelasi r = 0,2 dan p=0,026 maupun nilai ET r = 0,151 dan p = 0,110 . Terdapat perbedaan rerata kadar asam urat antara kelompok steatosis ringan dibandingkan steatosis sedang-berat 6,31 1,44 mg/dL vs 6,94 1,62 mg/dL, p = 0,03 . Tidak terdapat hubungan independen antara hiperurisemia dan derajat steatosis. Sedangkan faktor yang berhubungan secara independen dengan derajat fibrosis signifikan adalah hiperurisemia OR 2,450; 95 IK 1,054- 5,697 dan kenaikan kadar glukosa puasa OR 3,988 1,105-14,389 . Kelompok fibrosis signifikan mempunyai nilai rerata kadar asam urat yang lebih tinggi 6,89 1,60 mg/dL vs 6,42 1,50 mg/dL walau tidak bermakna secara statistik nilai p = 0,145 .Kesimpulan. Tidak terdapat korelasi antara kadar asam urat dengan nilai ET dan CAP

---

Background. Hyperuricemia is one of metabolic parameter which has been considered to play an important role in NAFLD. There is still lack of studies or evidence about correlation between serum uric acid level with liver disease progression.Aim of the study. To know the correlation between serum uric acid level and the steatosis and fibrosis degree of non alcoholic fatty liver disease evaluated using Controlled Attenuation Parameter CAP Transient Elastography TE examination.Methods. This study is a cross sectional study using secondary data of 113 NAFLD. Correlation between uric acid level and the degree of steatosis and fibrosis were also evaluated. Cutoff value for significant liver fibrosis ge 7 kPa. Mild and moderate severe steatosis diagnosed with a cutoff value of ge 285 dB m. Each metabolic factors were analyzed using chi square test. Univariate and multivariate analysis were performed using logistic regression test.Results. Of 113 NAFLD patients, there were 45 patients with moderate severe steatosis and 34 patients with significant fibrosis. There was no correlation between uric acid level and CAP correlation coefficient 0.2, P 0.026 and ET correlation coefficient 0.151, P 1,110 value were found. The difference of uric acid level mean value was found between mild steatosis and moderate severe steatosis 6.31 1.44 mg dL vs. 6.94 162 mg dL, P 0,03 . Hyperuricemia was not independent risk factor of moderate severe steatosis. High level of fasting blood glucose OR 3.98, 95 CI 1.105 14.389 and hyperuricemia OR 2.501, 95 CI 1.095 5.714 were found to be independent risk factors for significant liver fibrosis. Significant liver fibrosis group tends to have a higher mean value of uric acid level 6.89 1.60 mg dL vs. 6.42 1,50 mg dL with a p value 0,145.Conclusion. There was no correlation between uric acid an CAP TE value"

"Latar belakang. Hiperurisemia merupakan salah satu parameter metabolik yang diperkirakan mempunyai peranan dalam perjalanan non-alcoholic liver disease NAFLD . Studi mengenai peranan asam urat dalam progresivitas penyakit hati masih terbatas. Tujuan. Mengetahui korelasi antara kadar asam urat dengan nilai Elastografi Transien ET dan Controlled Attenuation Parameter CAP pasien NAFLD. Metode. Penelitian ini merupakan studi potong lintang dengan menggunakan data sekunder yang melibatkan 113 pasien NAFLD dewasa. Dilakukan uji korelasi antara kadar asam urat dengan nilai ET dan nilai CAP. Lalu dilakukan analisis tambahan dengan membagi pasien menjadi 2 kelompok berdasarkan nilai ET dan CAP. Nilai titik potong ET untuk fibrosis signifikan sebesar ge; 7 kPa dan nilai CAP ge; 285 dB/m digunakan untuk membedakan steatosis ringan dan steatosis sedangberat. Faktor metabolik yang mempengaruhi derajat steatosis dan fibrosis dianalisis dengan menggunakan uji chi-square dan dilakukan analisis regresi logistik. Hasil. Terdapat 45 pasien dengan steatosis sedang-berat dan 34 pasien yang mengalami fibrosis signifikan. Tidak terdapat korelasi antara kadar asam urat dengan nilai CAP koefisien korelasi r = 0,2 dan p=0,026 maupun nilai ET r = 0,151 dan p = 0,110 . Terdapat perbedaan rerata kadar asam urat antara kelompok steatosis ringan dibandingkan steatosis sedang-berat 6,31 1,44 mg/dL vs 6,94 1,62 mg/dL, p = 0,03 . Tidak terdapat hubungan independen antara hiperurisemia dan derajat steatosis. Sedangkan faktor yang berhubungan secara independen dengan derajat fibrosis signifikan adalah hiperurisemia OR 2,450; 95 IK 1,054- 5,697 dan kenaikan kadar glukosa puasa OR 3,988 1,105-14,389 . Kelompok fibrosis signifikan mempunyai nilai rerata kadar asam urat yang lebih tinggi 6,89 1,60 mg/dL vs 6,42 1,50 mg/dL walau tidak bermakna secara statistik nilai p = 0,145. Kesimpulan. Tidak terdapat korelasi antara kadar asam urat dengan nilai ET dan CAP.

---

Background. Hyperuricemia is one of metabolic parameter which has been considered to play an important role in NAFLD. There is still lack of studies or evidence about correlation between serum uric acid level with liver disease progression.

Aim of the study. To know the correlation between serum uric acid level and the steatosis and fibrosis degree of non alcoholic fatty liver disease evaluated using Controlled Attenuation Parameter CAP Transient Elastography TE examination.

Methods. This study is a cross sectional study using secondary data of 113 NAFLD. Correlation between uric acid level and the degree of steatosis and fibrosis were also evaluated. Cutoff value for significant liver fibrosis ge 7 kPa. Mild and moderate severe steatosis diagnosed with a cutoff value of ge 285 dB m. Each metabolic factors were analyzed using chi square test. Univariate and multivariate analysis were performed using logistic regression test.

Results. Of 113 NAFLD patients, there were 45 patients with moderate severe steatosis and 34 patients with significant fibrosis. There was no correlation between uric acid level and CAP correlation coefficient 0.2, P 0.026 and ET correlation coefficient 0.151, P 1,110 value were found. The difference of uric acid level mean value was found between mild steatosis and moderate severe steatosis 6.31 1.44 mg dL vs. 6.94 162 mg dL, P 0,03 . Hyperuricemia was not independent risk factor of moderate severe steatosis. High level of fasting blood glucose OR 3.98, 95 CI 1.105 14.389 and hyperuricemia OR 2.501, 95 CI 1.095 5.714 were found to be independent risk factors for significant liver fibrosis. Significant liver fibrosis group tends to have a higher mean value of uric acid level 6.89 1.60 mg dL vs. 6.42 1,50 mg dL with a p value 0,145.

Conclusion. There was no correlation between uric acid an CAP TE value."

"Nama : Irena UjiantiProgram Studi : Program Magister Ilmu BiomedikJudul Tesis :Dampak Restriksi Vitamin B12 Terhadap Kadar Homosistein, Resistensi Insulin Dan Gambaran NAFLDPembimbing : dr. Imelda Rosalyn Sianipar, M.Biomed, Ph.D dan Dr. dr. Dewi Irawati Soeria Santoso, MS Latar Belakang: Perlemakan hati merupakan penyakit hati kronik terbesar di dunia. Kondisi yang mendasari terjadinya perlemakan hati dimulai dari kondisi resistensi insulin. Salah satu patogenesis terjadinya resistensi insulin adalah gangguan pada pensinyalan insulin oleh zat toksik tertentu yang akan berinteraksi dengan protein yang menyusun jalur pensinyalan insulin. Peningkatan homosistein dikaitkan dengan resistensi insulin. Homosistein akan meningkat sejalan dengan terganggunya jalur metilasi dari siklus metionin. Pemberian diet restriksi vitamin B12 akan memicu terjadinya resistensi insulin lewat jalur stres oksidatif yang ditimbulkan oleh homosistein.Bahan dan Metode: Penelitian ini menggunakan metode eksperimental terhadap 24 tikus Sprague Dawley jantan Rattus norvegicus, 300-350 gram, usia 35-40 minggu , terbagi ke dalam 4 kelompok yaitu kontrol K , Kelompok perlakuan 4 minggu P-1 , Kelompok Perlakuan 8 minggu P-2 dan kelompok perlakuan 12 minggu P-3 . Pada Kelompok kontrol, diberikan diet standar AIN-93M sedangkan kelompok perlakuan diberikan pakan modifikasi restriksi vitamin B12 AIN-93 sesuai usia perlakuan.Hasil: Kelompok perlakuan 8 minggu paling baik dalam menggambarkan kondisi perlemakan hati dibandingkan kelompok kontrol dan perlakuan 4 minggu, sedangkan kelompok perlakuan 12 minggu telah mempresentasikan kondisi NASH Non Alcoholic Steatohepatitis . Hasil ini sejalan dengan kondisi peningkatan homosistein plasma pada kelompok kontrol dan masing-masing usia perlakuan.Kesimpulan: Peningkatan homosistein akibat diet restriksi vitamin B12 mengakibatkan kondisi steatosis dan steatohepatitits pada hati, sebagai akibat dari kondisi resistensi insulin dan kerusakan sebagian dari sel beta pankreas. Kata kunci: Homosistein, Restriksi vitamin B12, NAFLD, Resistensi Insulin

---

ABSTRACT Name Irena UjiantiStudy Program Master Program of Biomedical SciencesThesis Title Impact of Vitamin B12 Restriction on Homocysteine Levels, Insulin Resistance and NAFLDCounselor dr. Imelda Rosalyn Sianipar, M.Biomed, Ph.D. dr. Dewi Irawati Soeria Santoso, MS Background The fatty liver is the biggest chronic liver disease in the world. The underlying condition of fatty liver starts from the condition of insulin resistance. One of the pathomechanisms of insulin resistance is the disturbance in insulin signaling by certain toxic substances that will interact with one of the proteins that make up the insulin signaling pathway. Increased homosisteine is associated with insulin resistance. Homosisteine will increase in line with the disruption of the methionin metionin pathway. Dietary vitamin B12 deficiency will trigger insulin resistance through the path of oxidative stress generated by homocysteine.Materials and Methods This study used an experimental method of 24 male Sprague Dawley rats Rattus norvegicus, 300 400 gram, age 7 8 months , divided into 4 groups kontrol K , 4 weeks treatment group P 1 , 8 weeks treatment group P 2 and 12 week treatment group P 3 . In the kontrol group, a standard AIN 93 diet was administered while the feeding group was administered vitamin A deficiency deficiency AIN 93M according to treatment age.Results The best 8 weeks treatment group described the conditions of fatty liver compared to the 4 week kontrol and treatment group, while the 12 week treatment group presented the NASH condition. These results are consistent with the elevated plasma homocysteine conditions in the kontrol group and each treatment age.Conclusion Increased homocysteine due to dietary vitamin B12 deficiency is able to induce the condition of steatosis and steatohepatitits in the liver, as a result of the condition of insulin resistance and beta cell pancrease damage as the underlying patomechanism. Keywords Homocysteine, vitamin B12 Deficiency, NAFLD, Insulin Resistance "

"Komplikasi penyakit perlemakan hati non-alkoholik (PHNA) ditemukan pada 67% populasi memenuhi kriteria sindrom metabolik. Acalypha indica L. (AI) adalah herbal yang telah diketahui memiliki efek anti-oksidan, dan anti-inflamasi. Penelitian ini bertujuan membuktikan efek AI terhadap mekanisme pertahanan imun yang dibawa. Penelitian dilakukan dengan molecular docking terhadap senyawa AI pada TLR9, NFκB, TNFα, dan perubahan histopatologik hati. Model hewan steatohepatitis pada tikus Sprague-Dawley didapat dari induksi diet tinggi fruktosa, dan kolesterol (DTFK) selama 12 minggu. Terapi diberikan selama 8 minggu. Dua puluh lima tikus dibagi ke dalam 5 kelompok: Normal (K1), DTFK (K2), DTFK+AI, 400 mg (K3), kombinasi AI, 400 mg +gemfibrozil (Gem) 31 mg (K4) dan Gem 31 mg (K5) masing-masing per kgBB. Molecular docking untuk mengidentifikasi interaksi antara molekul hidrogen senyawa AI dengan residu asam amino TLR9, NFκB, TNFα. Perubahan morfologi hati dinilai dengan cara skoring. Analisis statistik yang dilakukan adalah uji Kruskall Wallis post hoc Mann Whitney, dilanjutkan dengan uji korelasi Spearman. Hasil molecular docking menunjukkan, selain senyawa flavonoid, ditemukan senyawa alkaloid beta-sitosterol, dan stigmasterol yang dapat berikatan dengan ketiga marker inflamasi dengan nilai binding energy terbaik. Senyawa lain dasycarpidan-1-methanol, acetate (ester), fenofibrate, quinine. Pemberian AI menurunkan hipertrofi (p=0,031), steatosis makrovesikular (p=0,018), fokus inflamasi (p=0,005). Pemberian AI juga menurunkan ekspresi TLR9 (p=0,009), NFκB (p=0,009), TNFα (p=0,009), akan tetapi tidak sebaik pemberian kombinasi AI+Gem.

---

Complications of non-alcoholic fatty liver disease (NAFLD) include 67% of the criteria for metabolic syndrome. Acalypha indica L., (AI) which is one of a herbal plant had been known as anti-oxidant and anti-inflammatory effects. The effect of AI for therapy investigated by looking of the immune defense mechanisms. This researched was assessed by molecular docking approached on TLR9, NFκB, TNFα expression and liver morphological changes. Animal models of steatohepatitis were collected from high- fructose and cholesterol diet (HFCD) of Sprague-Dawley rats for 12 weeks and followed by therapy for 8 weeks. There were 5 groups from twenty five researched rats, include normal group (K1), HFCD group (K2), HFCD group supplemented with 400 mg Acalypha indica L. (K3), combination between 400 mg AI.+gemfibrozil (Gem) 31 mg (K4) and Gem 31 mg/kg (K5) in kgBW, respectively. The results of molecular docking were carried out by assessing the interaction between hydrogen molecules of AI compounds and amino acid residues in TLR9, NFκB, TNFα. Morphological changes were assessed by scoring system. Statistical analyzed used Kruskall Wallis with post hoc Mann Whitney test continued by Spearman correlation test. The molecular docking analysis showed that, an alkaloid compounds were found besides the flavonoid compounds that can bind to the binding pocket of inflammatory markers with the best binding energies. Other compounds, there are dasycarpidan-1-methanol, acetate (ester), fenofibrate and quinine. Supplementation of AI would reduced hypertrophy (p=0.031), macrovesicular steatosis (p=0.018), inflammation foci (p=0.005) and also decreased of TLR9 (p=0.009), NFκB (p=0.009), TNFα (p=0.009) expression, but not as good as the combination of AI+Gem."

"Latar Belakang. Penyakit ginjal kronik (PGK) dan penyakit perlemakan hati terkait metabolik (Metabolic Associated Fatty Liver Disease, MAFLD) berbagi beberapa faktor risiko metabolik penting dan mekanisme patofisiologis. Hingga saat ini, belum diketahui besarnya masalah MAFLD pada populasi PGK-dialisis di Indonesia dan pengaruh berbagai faktor terhadap kejadian MAFLD. Tujuan. Mengetahui faktor-faktor yang berhubungan dengan MAFLD pada pasien PGK yang menjalani hemodialisis rutin. Metode. Studi potong lintang dengan populasi terjangkau adalah pasien PGK yang menjalani hemodialisis di Unit Dialisis dan Transplantasi Ginjal Gedung CMU 1 Lantai 8, RSUPN Cipto Mangunkusumo pada Maret hingga Mei 2024. Selanjutnya dilakukan anamnesis, pemeriksaan fisik, pemeriksaan darah dan penilaian CAP dengan alat transien elastografi. Analisis data dilakukan untuk mengetahui faktor-faktor yang berhubungan dengan MAFLD pada pasien PGK yang menjalani hemodialisis rutin. Hasil. Sebanyak 99 individu diikutsertakan pada penelitian ini dan didapatkan prevalensi MAFLD sebesar 31,31%. MAFLD lebih banyak ditemukan pada lemak viseral berisiko, kadar CRP tinggi, usia ≥50 tahun, diabetes melitus, dislipidemia, adekuasi dialisis yang buruk dan fungsi ginjal sisa ≥100 ml. Analisis bivariat mendapatkan lemak viseral berisiko, diabetes melitus dan adekuasi dialisis yang buruk berhubungan dengan kejaidan MAFLD. Analisis multivariat mendapatkan lemak viseral berisiko dan adekuasi dialisis yang buruk merupakan faktor yang berhubungan dengan terjadinya MAFLD pada pasien gagal ginjal dengan hemodialisis rutin. Kesimpulan. Lemak viseral berisiko dan adekuasi dialisis yang buruk merupakan faktor yang berhubungan dengan terjadinya MAFLD pada pasien gagal ginjal dengan hemodialisis rutin.

---

Background. Chronic kidney disease (CKD) and metabolic-associated fatty liver disease (MAFLD) share several important metabolic risk factors and pathophysiological mechanisms. Until now, the magnitude of the MAFLD problem in the CKD-dialysis population in Indonesia is unknown and the influence of various factors on the incidence of MAFLD. Objective. To determine the factors associated with MAFLD in CKD patients undergoing routine hemodialysis. Methods. This cross-sectional study was conducted on an accessible population of CKD patients who underwent hemodialysis at the Dialysis and Kidney Transplant Unit, CMU Building 1, Floor 8, Cipto Mangunkusumo Hospital from March to May 2024. Anamnesis, physical examination, blood test and CAP assessment with transient elastography were performed. Data analysis was conducted to determine factors associated with MAFLD in CKD patients undergoing routine hemodialysis. Results. A total of 99 individuals were included in this study and the prevalence of MAFLD was found to be 31.31%. MAFLD is more commonly found in at-risk visceral fat, high CRP levels, age ≥50 years, diabetes mellitus, dyslipidemia, poor dialysis adequacy and residual renal function ≥100 ml. Bivariate analysis found that risky visceral fat, diabetes mellitus and poor dialysis adequacy were associated with the occurrence of MAFLD. Multivariate analysis found that risky visceral fat and poor dialysis adequacy were factors associated with the occurrence of MAFLD in kidney failure patients on routine hemodialysis. Conclusion. Risky visceral fat and poor dialysis adequacy are factors associated with the occurrence of MAFLD in renal failure patients on routine hemodialysis"

"ABSTRAKAim: to know the effectiveness of probiotic in reducing hepatic inflammation among non-alcoholic fatty liver disease (NAFLD) patients. Methods: we performed literature searching regarding the potential role of probiotic in reducing hepatic inflammation among NAFLD patients. Results: six articles were finally critically appraised. All six studies had good validity and importance. These studies unanimously reported that probiotic is useful in reducing hepatic inflammation, and liver fat content. However, further evidence is needed to show whether or not probiotic is beneficial reducing cirrhosis progression and liver-related mortality. Conclusion: probiotic owns robust potential to treat NAFLD. Probiotic reduce hepatic inflammation, as shown by the reduction of liver aminotransferase, and inflammatory markers. Based on this evidence based report, probiotic is a promising adjunct therapy for NAFLD."